Font, Albert http://orcid.org/0000-0003-3908-1111
Mellado, Begona
Climent, Miguel A.
Virizuela, Juan Antonio
Oudard, Stephane
Puente, Javier
Castellano, Daniel
González-del-Alba, Aranzazu
Pinto, Alvaro
Morales-Barrera, Rafael
Rodriguez-Vida, Alejo
Fernandez, Pedro L.
Teixido, Cristina
Jares, Pedro
Aldecoa, Iban
Gibson, Neil
Solca, Flavio
Mondal, Shoubhik
Lorence, Robert M.
Serra, Josep
Real, Francisco X. http://orcid.org/0000-0001-9501-498X
Article History
Received: 2 November 2022
Revised: 31 October 2023
Accepted: 21 November 2023
First Online: 15 December 2023
Competing interests
: AF has served for an advisory council or committee for Janssen, Astellas, Sanofi, Roche, EUSA, AstraZeneca; and received grants or funds from AstraZeneca, Pierre Fabre. BM has received grants or funds (recipient: herself) from Janssen, Roche, Astellas, Sanofi, Bayer; speaker bureau and travel accommodation fees from Pfizer, Ipsen, Janssen, Roche; and speaker bureau fees from Astellas, Sanofi, Bristol-Myers Squibb, Bayer. MAC has received honoraria for speaker engagements, advisory roles and continuous medical education from Janssen, AstraZeneca, Astellas, Merck Sharp & Dohme, Pfizer, EUSA MSD, Roche, Ipsen, Sanofi, Merck, Bristol-Myers Squibb. SO has received honoraria, consulting fees and any other potential financial relationship from Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, Merck, Novartis, Astellas, Janssen, Ipsen, AstraZeneca; and grants or funds from Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, Janssen, Ipsen, AstraZeneca. JP has received honoraria for speaker engagements, advisory roles or continuous medical education from Astellas, AstraZeneca, Janssen, Merck Sharp & Dohme, Bayer, Pfizer, Eisai, Ipsen, Sanofi, Roche, Bristol-Myers Squibb, Pierre Fabre, Merck; research funding from Astellas, Pfizer; and consultancy fees from Astellas and Roche. DC has received honoraria from Pfizer, Bristol-Myers Squibb, Roche, Janssen, Astellas, Novartis, Exelisis, Ipsen, Bayer, Lilly, Eisai, Merck Sharp & Dohme; and grants or funds from Janssen, Astellas. AG-d-A has received research funding from Astellas; travel grants from Astellas, Jansen, Sanofi, Bristol-Myers Squibb, Roche, Pfizer, Ipsen; and honoraria for speaker engagements, advisory boards and continuous medical education from Janssen, Astellas, Sanofi, Bayer, Roche, Ipsen, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, EUSA Pharma, Eisai, AstraZeneca. AP has received consulting fees from Pfizer, Bristol-Myers Squibb, Ipsen, Astellas, Janssen, Merck Sharp & Dohme, Merck, Clovis, Roche, Bayer, Sanofi, Novartis; and grants or funds from Pfizer, Bristol-Myers Squibb. RM-B (all unrelated in the last 3 years) has received consulting or advisory and/or speakers bureau fees from Sanofi Aventis, AstraZeneca, Merck Sharp & Dohme, Astellas, Bristol-Myers Squibb; and travel and accommodations expenses from Roche, Sanofi Aventis, Astellas, Janssen, Merck Sharp & Dohme, Bayer, Pfizer. PLF has received non-personal fees from collaborations with Diaceutics. CT has received research funding from Novartis; consulting or advisory and/or speakers bureau fees from Diaceutics, Pfizer, Novartis, AstraZeneca, Takeda, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme. IA has received travel grants from Sysmex. NG, FS, SM, RML and JS report employment with Boehringer Ingelheim. RML also declares being a paid consultant to Boehringer Ingelheim. All the other authors declare no potential conflict of interest.
: The study was approved by the institutional review boards of the participating centres before trial initiation. Informed consent was obtained from each participant included in the study. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.